Segall Bryant & Hamill LLC Trims Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Segall Bryant & Hamill LLC lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 3.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 303,467 shares of the company’s stock after selling 12,395 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Surgery Partners were worth $9,784,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP raised its position in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after acquiring an additional 1,760 shares during the period. KBC Group NV raised its position in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. Creative Planning purchased a new position in Surgery Partners in the 3rd quarter valued at about $258,000. Finally, Versor Investments LP acquired a new stake in Surgery Partners in the 3rd quarter worth about $271,000.

Surgery Partners Trading Up 3.8 %

NASDAQ SGRY opened at $23.36 on Friday. Surgery Partners, Inc. has a 12 month low of $21.36 and a 12 month high of $36.92. The stock has a market capitalization of $2.97 billion, a P/E ratio of -48.67, a PEG ratio of 16.71 and a beta of 2.76. The firm’s 50-day moving average is $30.15 and its two-hundred day moving average is $28.40. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the prior year, the company posted $0.15 earnings per share. The business’s revenue was up 14.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Surgery Partners, Inc. will post 0.83 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. UBS Group assumed coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price for the company. Royal Bank of Canada lowered their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday. KeyCorp started coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a report on Tuesday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus price target of $38.71.

Get Our Latest Analysis on Surgery Partners

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.